"They are able to process significant volumes for us very efficiently and leverage their knowledge of the sector to flag risks and issues."
Chambers UK - 2016Medicinal Cannabis: the new frontier
Medicinal cannabis is, without doubt, one of the world’s fastest growing and most innovative industrial sectors. Since the turn of the century, researchers have revealed the immense potential of the drug to treat conditions from epilepsy to MS to cancer.
As a result, many countries have legalised cannabis for medicinal use, and a new sector has emerged that could be worth €115.7 billion by 2028 in Europe alone. But this is a complex new area. Memery Crystal has the expertise to help you navigate it.
Your team
Nick DavisChief Executive
Daniel AbrahamsPartner, Co-Head of Real Estate
Nick AlfilléPartner
Michael DawesPartner, Head of Corporate
Kieran StonePartner
Daniel TunkelPartner, Head of Financial Regulation
Mark O’DonnellSenior Associate
Melanie Talbot (née Jory)Director
Robert BlackAssociate
Lauren BelmonteSolicitor
Max BinneySolicitor
Thomas GraceSolicitor
In 2018, the UK started the process of legalising medicinal cannabis. At Memery Crystal, we believe this law change represents a chance to benefit thousands of patients, support scientific innovation and fuel economic prosperity. We are committed to supporting this exciting opportunity.
The UK medicinal cannabis sector may be embryonic, but we are already at the centre of it. We have worked closely with international investors and advised companies on UK market listings.
Our team is well equipped to advise on the broad range of matters that this complex but highly promising new space encompasses.